These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25069959)

  • 1. Long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement following rotablation for severely calcified lesions: a retrospective nonrandomized study.
    Tsutsumi J; Ishikawa T; Nakano Y; Yoshimura M; Mutoh M
    Cardiovasc Interv Ther; 2015 Jan; 30(1):29-37. PubMed ID: 25069959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity score matched lesion-based comparison of long-term clinical and angiographic outcomes after placement of sirolimus (Cypher Bx Velocity) and paclitaxel (TAXUS Express)-eluting stents for de novo native coronary stenosis.
    Nakano Y; Ishikawa T; Hino S; Mutoh M
    Cardiovasc Interv Ther; 2014 Apr; 29(2):93-101. PubMed ID: 24122399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective comparison of midterm clinical and angiographic outcomes after the implantation of paclitaxel- and sirolimus-eluting stents for de novo coronary complex lesions in nonrandomized Japanese patients.
    Ishikawa T; Nakano Y; Mutoh M
    Intern Med; 2012; 51(19):2695-701. PubMed ID: 23037458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis.
    Tsujita H; Hamazaki Y; Nishikura T; Yokota H; Kondo S; Hosokawa S; Tsukamoto S; Mutou M; Sakurai M; Nishimura H; Kobayashi Y
    Cardiovasc Interv Ther; 2013 Jan; 28(1):9-15. PubMed ID: 23054964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-discharge clinical and angiographic outcomes of patients presenting within 48h of STEMI treated with paclitaxel- or sirolimus-eluting stents.
    Ishikawa T; Mutoh M; Nakano Y; Suzuki T; Nakata K; Murakami A; Miyamoto T; Yoshimura M
    J Cardiol; 2012 Sep; 60(3):174-9. PubMed ID: 22727627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison.
    Miyamoto T; Ishikawa T; Nakano Y; Mutoh M
    Cardiovasc Interv Ther; 2017 Jan; 32(1):24-35. PubMed ID: 26979599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of the clinical and angiographic outcomes of the sirolimus-eluting stent and the bare-metal stent in 2031 nonrandomized consecutive de novo native coronary lesions.
    Kubota T; Ishikawa T; Mutoh M
    Intern Med; 2011; 50(21):2463-70. PubMed ID: 22041343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score-matched lesion-based comparison of mid-term angiographic outcomes of TAXUS Liberté with Cypher Bx Velocity stents for de novo native coronary stenosis and in patients with diabetes.
    Suzuki T; Ishikawa T; Nakano Y; Hino S; Mutoh M
    Intern Med; 2014; 53(12):1265-73. PubMed ID: 24930644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month angiographic and one-year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent.
    Dang Q; Li YJ; Gao L; Jin Z; Gou LX
    Chin Med J (Engl); 2012 Oct; 125(19):3393-7. PubMed ID: 23044294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels.
    Nakano Y; Ishikawa T; Mutoh M
    Cardiovasc Interv Ther; 2015 Oct; 30(4):327-37. PubMed ID: 25673511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
    Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
    J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience .
    Lee S; Yoon CH; Oh IY; Suh JW; Cho YS; Cho GY; Chae IH; Choi DJ; Youn TJ
    Int Heart J; 2015; 56(1):6-12. PubMed ID: 25503656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions.
    Ishikawa T; Mutoh M; Nakano Y; Endo A; Kubota T; Suzuki T; Nakata K; Murakami A; Miyamoto T; Sakamoto H; Okada H; Imai K; Yoshimura M
    J Cardiol; 2011 Jan; 57(1):44-52. PubMed ID: 21146366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.
    Barbash IM; Minha S; Torguson R; Ben-Dor I; Badr S; Loh JP; Satler LF; Pichard AD; Waksman R
    J Invasive Cardiol; 2014 Apr; 26(4):154-60. PubMed ID: 24717271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
    Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
    Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midterm outcomes of bare-metal stenting after primary stenting for ST-segment elevated myocardial infarctions in the drug-eluting stent era: a propensity score-matched comparison with sirolimus-eluting stent.
    Nakata K; Ishikawa T; Nakano Y; Yoshimura M; Mutoh M
    Cardiovasc Interv Ther; 2015 Jul; 30(3):234-43. PubMed ID: 25420640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
    Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.